Replies to post #231818 on NorthWest Biotherapeutics Inc (NWBO)

[Kam8]

JUNO and KITE were acquired by BP before any good data, and valuation were 9B and 12B. They are toxic and just for liquid cancers only. I am sure BPs are very interested in Nwbo. And their trials are fail in GBM. If I were short I will cover my short positions within 3 months.